Yu T-C, Chou W-C. Challenges of Hepatitis B Virus Reactivation and CD19 Testing Following Tafasitamab Plus Lenalidomide for Relapsed Diffuse Large B-Cell Lymphoma. J Med Cases [Internet]. 2026 Jan. 1 [cited 2026 Mar. 28];17(5):231-7. Available from: https://jmc.elmerpub.com/index.php/jmc/article/view/5313